Dr Lalchandani Labs Stock Price Analysis and Quick Research Report. Is Dr Lalchandani Labs an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dr Lalchandani Labs. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dr Lalchandani Labs has a PE ratio of 26.9410179330362 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dr Lalchandani Labs has ROA of 3.7755% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dr Lalchandani Labs has a Current ratio of 1.8849.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dr Lalchandani Labs has a ROE of 6.7002%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dr Lalchandani Labs has a Debt to Equity ratio of 0.3652 which means that the company has low proportion of debt in its capital.

• Sales growth: Dr Lalchandani Labs has reported revenue growth of -4.5772% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dr Lalchandani Labs for the current financial year is 3.24981806840628%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dr Lalchandani Labs is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dr Lalchandani Labs is Rs 0.9647. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dr Lalchandani Labs in Ticker for free. Also, one can get the intrinsic value of Dr Lalchandani Labs by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dr Lalchandani Labs FAQs

Q1. What is Dr Lalchandani Labs share price today?
Ans: The current share price of Dr Lalchandani Labs is Rs 25.99.

Q2. What is the market capitalisation of Dr Lalchandani Labs?
Ans: Dr Lalchandani Labs has a market capitalisation of Rs 11.261643732 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dr Lalchandani Labs?
Ans: The PE ratio of Dr Lalchandani Labs is 26.9410179330362 and the P/B ratio of Dr Lalchandani Labs is 1.18234175545224, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dr Lalchandani Labs share?
Ans: The 52-week high share price of Dr Lalchandani Labs is Rs 28.7, and the 52-week low share price of Dr Lalchandani Labs is Rs 9.8.

Q5. Does Dr Lalchandani Labs pay dividends?
Ans: Currently, Dr Lalchandani Labs does not pay dividends. Dividend yield of Dr Lalchandani Labs is around 0%.

Q6. What are the face value and book value of Dr Lalchandani Labs shares?
Ans: The face value of Dr Lalchandani Labs shares is Rs 10, while the book value per share of Dr Lalchandani Labs is around Rs 21.9818. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dr Lalchandani Labs?
Ans: Dr Lalchandani Labs has a total debt of Rs 3.4784 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dr Lalchandani Labs?
Ans: The ROE of Dr Lalchandani Labs is 6.7002% and ROCE of Dr Lalchandani Labs is 7.0704%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dr Lalchandani Labs a good buy for the long term?
Ans: The Dr Lalchandani Labs long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dr Lalchandani Labs undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dr Lalchandani Labs appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dr Lalchandani Labs’s financials?
Ans: You can review Dr Lalchandani Labs’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.